Inflammation is the body’s defence system, a way of responding to injury or infection. One key molecule involved in the ...
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...
Positive clinical data validates commencement of a larger Phase 2b clinical trial in elderly patients post-hip fracture Drug shown to decrease biomarkers associated with TNF-alpha activation in ...
A new study suggests that suppressing inflammation after surgery may prolong pain instead of relieving it. Taking anti-inflammatory medication after an operation is a common part of care. However, a n ...
Positive clinical data validates current Phase 2b clinical trial of isomyosamine as a treatment for chronic inflammation associated with muscle loss BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, ...
TNF Pharmaceuticals (TNFA) announced that it has entered into a collaborative agreement with Renova Health for a planned trial of its TNF-alpha inhibitor drug isomyosamine as a treatment for ...
Researchers in Japan are exploring a future where the body itself becomes a health monitor, no screens or batteries required.
Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system homeostasis. When the immune system malfunctions, irregularities in cytokine ...
Machine learning technology used to identify patients for studies of muscle mass preservation during GLP-1 treatment BALTIMORE--(BUSINESS WIRE)-- TNF Pharmaceuticals, Inc. (TNFA) (“TNF” or the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback